Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor

被引:589
作者
Denison, Michael S. [1 ]
Soshilov, Anatoly A. [1 ]
He, Guochun [1 ]
DeGroot, Danica E. [1 ]
Zhao, Bin [2 ]
机构
[1] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA
[2] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China
基金
美国国家卫生研究院;
关键词
Ah receptor; AhR; dioxin; mechanism; promiscuity; HAHs; PAHs; LIGAND-DEPENDENT RECRUITMENT; ABNORMAL LIVER DEVELOPMENT; TRANSFORMED AH-RECEPTOR; GENE-EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TRANSCRIPTION FACTOR; BINDING DOMAIN; POLYCHLORINATED-BIPHENYLS; ENVIRONMENTAL-POLLUTANTS; AROMATIC-HYDROCARBONS;
D O I
10.1093/toxsci/kfr218
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The Ah receptor (AhR) is a ligand-dependent transcription factor that mediates a wide range of biological and toxicological effects that result from exposure to a structurally diverse variety of synthetic and naturally occurring chemicals. Although the overall mechanism of action of the AhR has been extensively studied and involves a classical nuclear receptor mechanism of action (i.e., ligand-dependent nuclear localization, protein heterodimerization, binding of liganded receptor as a protein complex to its specific DNA recognition sequence and activation of gene expression), details of the exact molecular events that result in most AhR-dependent biochemical, physiological, and toxicological effects are generally lacking. Ongoing research efforts continue to describe an ever-expanding list of ligand-, species-, and tissue-specific spectrum of AhR-dependent biological and toxicological effects that seemingly add even more complexity to the mechanism. However, at the same time, these studies are also identifying and characterizing new pathways and molecular mechanisms by which the AhR exerts its actions and plays key modulatory roles in both endogenous developmental and physiological pathways and response to exogenous chemicals. Here we provide an overview of the classical and nonclassical mechanisms that can contribute to the differential sensitivity and diversity in responses observed in humans and other species following ligand-dependent activation of the AhR signal transduction pathway.
引用
收藏
页码:1 / 22
页数:22
相关论文
共 168 条
[1]  
AARTS JMM, 1996, EUR J PHARMACOL, V293, P463
[2]   3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor α [J].
Abdelrahim, M ;
Ariazi, E ;
Kim, K ;
Khan, S ;
Barhoumi, R ;
Burghardt, R ;
Liu, SX ;
Hill, D ;
Finnell, R ;
Wlodarczyk, B ;
Jordan, VC ;
Safe, S .
CANCER RESEARCH, 2006, 66 (04) :2459-2467
[3]   Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells [J].
Abdelrahim, M ;
Smith, R ;
Safe, S .
MOLECULAR PHARMACOLOGY, 2003, 63 (06) :1373-1381
[4]   An introduction to the molecular basics of aryl hydrocarbon receptor biology [J].
Abel, Josef ;
Haarmann-Stemmann, Thomas .
BIOLOGICAL CHEMISTRY, 2010, 391 (11) :1235-1248
[5]   Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells:: Greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners [J].
Abnet, CC ;
Tanguay, RL ;
Heideman, W ;
Peterson, RE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 159 (01) :41-51
[6]   Dioxin Increases the Interaction Between Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha at Human Promoters [J].
Ahmed, Shaimaa ;
Valen, Eivind ;
Sandelin, Albin ;
Matthews, Jason .
TOXICOLOGICAL SCIENCES, 2009, 111 (02) :254-266
[7]  
Andea A, 2009, LAB INVEST, V89, p100A
[8]   Thiol-Based Redox Switches and Gene Regulation [J].
Antelmann, Haike ;
Helmann, John D. .
ANTIOXIDANTS & REDOX SIGNALING, 2011, 14 (06) :1049-1063
[9]   CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor [J].
Anttila, S ;
Tuominen, P ;
Hirvonen, A ;
Nurminen, M ;
Karjalainen, A ;
Hankinson, O ;
Elovaara, E .
PHARMACOGENETICS, 2001, 11 (06) :501-509
[10]   An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes [J].
Anttila, S ;
Lei, XD ;
Elovaara, E ;
Karjalainen, A ;
Sun, WM ;
Vainio, H ;
Hankinson, O .
PHARMACOGENETICS, 2000, 10 (08) :741-751